Table 1.
Demographic, clinical and laboratory features
| Characteristics | CD (n = 26) | GITB (n = 26) | P value |
| Demographic features | |||
| Age (range), yr | 36.6 ± 8.6 (6-79) | 37.2 ± 9.6 (18-78) | NS |
| Sex (male:female) ratio | 16:10 | 15:11 | NS |
| Clinical features | |||
| Duration of symptoms (range), mo | 58.1 ± 9.8 (8-240) | 7.2 ± 3.4 (2-24) | S |
| Chronic diarrhoea, n (%) | 18 (69.2) | 9 (34.6) | S |
| Hematochezia, n (%) | 8 (30.7) | 1 (3.8) | S |
| Fever, n (%) | 6 (23.1) | 18 (69.2) | S |
| Weight loss, n (%) | 18 (69.2) | 19 (73.1) | NS |
| Abdominal pain, n (%) | 17 (65.4) | 22 (84.6) | NS |
| Intestinal obstruction, n (%) | 5 (19.2) | 3 (11.5) | NS |
| Growth retardation, n (%) | 2 (7.7) | 0 (0) | NS |
| Ascites, n (%) | 2 (7.7) | 9 (34.6) | S |
| Abdominal lump, n (%) | 2 (7.7) | 4 (15.4) | NS |
| Extra-intestinal features, n (%) | 16 (61.5) | 6 (23.1) | S |
| Laboratory/radiological features | |||
| Anaemia, n (%) | 15 (57.7) | 7 (26.9) | S |
| Hypoproteinemia, n (%) | 11 (42.3) | 9 (34.6) | NS |
| ESR (range) mm at 1 h | 54.7 ± 12.2 (10-104) | 59.7 ± 13.6 (19-110) | NS |
| Pulmonary infiltration/fibrosis, n (%) | 1 (3.8) | 10 (38.4) | S |
| Abdominal lymphadenopathy, n (%) | 3 (11.5) | 11 (42.3) | S |
| Generalized lymphadenopathy, n (%) | 0 (0) | 2 (7.7) | NS |